Kleresca® achieves MDSAP certification
Ballerup, Denmark, December 2018. Kleresca®, a medical technology company focused on the development and commercialisation of a unique biophotonic technology in dermatology, has been certified according to The Medical Device Single Audit Program (MDSAP).Audited by the National Standards Authority of Ireland (NSAI), Kleresca® has been certified to be compliant with the standard and regulatory requirements for the medical device markets of Australia and Canada. With minor additional audits and approvals, the certification will also apply to Brazil, Japan and the United States. The MDSAP